Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans

Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans

As part of a regulatory commitment for post-licensure safety monitoring of live, oral human rotavirus vaccine (RV1), this study compared the incidence rates (IR) of intussusception, acute lower respiratory tract infection (LRTI) hospitalization, Kawasaki disease, convulsion, and mortality in RV1 rec...

Full description

Bibliographic Details
Main Authors: Veena Hoffman, Remon Abu-Elyazeed, Cheryl Enger, Daina B. Esposito, Michael C. Doherty, Scott C. Quinlan, Kathleen Skerry, Crystal N. Holick, Peter Basile, Leonard R. Friedland, Nicolas Praet, Stéphanie Wéry, Corinne Willame, David D. Dore, Dominique Rosillon
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
rotavirus vaccine
safety
health insurance claims data
intussusception
acute lower respiratory tract infection
kawasaki disease
convulsion
mortality
Online Access:http://dx.doi.org/10.1080/21645515.2018.1450123

Internet

http://dx.doi.org/10.1080/21645515.2018.1450123

Similar Items